Home
About
Overview
Sharing Data
ORCID
Help
History (6)
De novo sphingolipid biosynthesis necessitates detoxification in cancer cells.
Human autoimmune diabetes mellitus: lessons from BB rats and NOD mice--Caveat emptor.
Neutral Glycosphingolipids
Tobacco control interventions in the emergency department: a joint statement of emergency medicine organizations.
Drug-induced thrombocytopenia secondary to natalizumab treatment.
See All 6 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Drug-induced thrombocytopenia secondary to natalizumab treatment.
Cachia D, Izzy S, Berriosmorales I, Ionete C. Drug-induced thrombocytopenia secondary to natalizumab treatment. BMJ Case Rep. 2014 May 30; 2014.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Murine-Derived
Anti-Inflammatory Agents
Diagnosis, Differential
Female
Humans
Methylprednisolone
Middle Aged
Multiple Sclerosis, Relapsing-Remitting
Natalizumab
Prednisone
Rituximab
Thrombocytopenia
authors with profiles
Carolina Ionete MD, PhD
David M Cachia MD
Idanis M Berrios Morales MD